参考文献/References:
[1] Lew CCH, Yandell R, Fraser RJL, et al. Association Between Malnutrition and Clinical Outcomes in the Intensive Care Unit: A Systematic Review [Formula: see text]. JPEN J Parenter Enteral Nutr, 2017, 41(5): 744-758.
[2] Lopez-Giacoman S, Madero M. Biomarkers in chronic kidney disease, from kidney function to kidney damage. World J
Nephrol, 2015, 4(1): 57-73.
[3] Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function--a review. Clin Chem Lab Med,1999, 37(4): 389-395.
[4] Tetsuka S，Morita M，Ikeguchi K, et al. Creatinine/cystatin C ratio as a surrogate marker of residual muscle mass in amyotrophic lateral sclerosis. Neurology and Clinical Neuroscience, 2013,1(1)32-37.
[5] Kashani KB, Frazee EN, Kukralova L, et al. Evaluating Muscle Mass by Using Markers of Kidney Function: Development of the Sarcopenia Index. Critical care medicine, 2017, 45(1): e23-e29.
[6] Lien YH. Looking for Sarcopenia Biomarkers. Am J Med, 2017,130(5): 502-503.
[7] Haines RW, Zolfaghari P, Wan Y, et al. Elevated urea-tocreatinine ratio provides a biochemical signature of muscle catabolism and persistent critical illness after major trauma. Intensive care medicine, 2019, 45(12): 1718-1731.
[8] Lin YL, Chen SY, Lai YH, et al. Serum creatinine to cystatin C ratio predicts skeletal muscle mass and strength in patients with non-dialysis chronic kidney disease. Clin Nutr, 2020, 39(8):2435-2441.
[9] Komorita Y, Iwase M, Fujii H, et al. The serum creatinine to cystatin C ratio predicts bone fracture in patients with type 2 diabetes: The Fukuoka Diabetes Registry. Diabetes res clin pract, 2018, 146:202-210.
[10] Amado CA, Garcia-Unzueta MT, Lavin BA, et al. The Ratio Serum Creatinine/Serum Cystatin C (a Surrogate Marker of
Muscle Mass) as a Predictor of Hospitalization in Chronic Obstructive Pulmonary Disease Outpatients. Respiration, 2019, 97
(4): 302-309.
[11] Suzuki K, Furuse H, Tsuda T, et al. Utility of creatinine/cystatin C ratio as a predictive marker for adverse effects of chemotherapy in lung cancer: A retrospective study. J Int Med Res, 2015, 43(4):573-582.
[12] Adam AM, Nasir SAR, Merchant AZ, et al. Efficacy of serum blood urea nitrogen, creatinine and electrolytes in the diagnosis and mortality risk assessment of patients with acute coronary syndrome. Indian heart J, 2018, 70(3): 353-359.
[13] Ravn B, Prowle JR, Martensson J, et al. Superiority of Serum Cystatin C Over Creatinine in Prediction of Long-Term Prognosis at Discharge From ICU. Crit Care Med, 2017, 45(9): e932-e940.
[14] Barreto EF, Kanderi T, Dicecco SR, et al. Sarcopenia Index Is a Simple Objective Screening Tool for Malnutrition in the
Critically Ill. JPEN J Parenter Enteral Nutr, 2019, 43(6): 780-788.
[15] Barreto EF, Poyant JO, Coville HH, et al. Validation of the sarcopenia index to assess muscle mass in the critically ill: A
novel application of kidney function markers. Clin Nutr, 2019, 38(3): 1362-1367.
[16] Yang J, Zhang T, Feng D, et al. A new diagnostic index for sarcopenia and its association with short-term postoperative complications in patients undergoing surgery for colorectal cancer. Colorectal Dis, 2019, 21(5): 538-547.
[17] Yanishi M, Kinoshita H, Tsukaguchi H, et al. The creatinine cystatin C ratio provides effective evaluation of muscle mass in kidney transplant recipients. Int Urol Nephrol, 2019, 51(1): 79-83.
[18] Kashani K, Sarvottam K, Pereira NL, et al. The sarcopenia index: A novel measure of muscle mass in lung transplant candidates.Clin Transplant, 2018, 32(3): e13182.
[19] Wang S, Xie L, Xu J, et al. Predictive value of serum creatinine/cystatin C in neurocritically ill patients. Brain Behav, 2019, 9 (12): e01462.
[20] Yanishi M, Kinoshita H, Tsukaguchi H, et al. Dual Energy X-ray Absorptiometry and Bioimpedance Analysis are Clinically Useful for Measuring Muscle Mass in Kidney Transplant Recipients With Sarcopenia. Transplant Proc, 2018, 50(1): 150-154.
[21] Kuchnia A, Earthman C, Teigen L, et al. Evaluation of Bioelectrical Impedance Analysis in Critically Ill Patients: Results of a Multicenter Prospective Study. JPEN J Parenter Eenteral Nutr, 2017, 41(7): 1131-1138.
[22] He Q, Jiang J, Xie L, et al. A sarcopenia index based on serum creatinine and cystatin C cannot accurately detect either low muscle mass or sarcopenia in urban community-dwelling older people. Sci Rep, 2018, 8(1): 11534.
[23] Osaka T, Hamaguchi M, Hashimoto Y, et al. Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes. Diabetes Res Clin Pract, 2018,139:52-58.
[24] Kim SW, Jung HW, Kim CH, et al. A New Equation to Estimate Muscle Mass from Creatinine and Cystatin C. PloS one, 2016, 11 (2): e0148495.
[25] Mitsiopoulos N, Baumgartner RN, Heymsfield SB, et al. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol (1985), 1998, 85(1): 115-122.
[26] Kumarasamy N, Tishbi N, Mukundan S, et al. Cardiothoracic MRI in the ICU: A 10-Year Experience. Acad Radiol, 2018, 25 (3): 359-364.
[27] 蒋小芝, 王华伟, 赵浩天, 等 . 骨骼肌超声在急危重症病人营养状态评估中的应用 . 肠外与肠内营养, 2019, 26(6): 372-376.
[28] Heyland DK, Dhaliwal R, Jiang X, et al. Identifying critically ill patients who benefit the most from nutrition therapy: the
development and initial validation of a novel risk assessment tool. Crit care, 2011, 15(6): R268.
[29] Rahman A, Hasan RM, Agarwala R, et al. Identifying critically-ill patients who will benefit most from nutritional therapy: Further validation of the "modified NUTRIC" nutritional risk assessment tool. Clin Nutr, 2016, 35(1): 158-162.
[30] Machado Dos Reis A, Marchetti J, Forte Dos Santos A, et al. NUTRIC Score: Isolated and Combined Use With the NRS-2002 to Predict Hospital Mortality in Critically Ill Patients. JPEN J Parenter Enteral Nutr, 2020,44(7):1250-1256.
[31] Maciel LRMA , Franzosi OS, Nunes DSL, et al. Nutritional Risk Screening 2002 Cut-Off to Identify High-Risk Is a Good Predic‐tor of ICU Mortality in Critically Ill Patients. Nutr Clin Pract,2019, 34(1): 137-141.
相似文献/References:
[1]宫雪梅,叶向红,邢 娟,等.重症病人早期肠内营养喂养中断原因的系统评价[J].肠外与肠内营养杂志,2018,(05):285.[doi:10.16151/j.1007-810x.2018.05.008]
GONG Xue-mei,YE Xiang-hong,XING Juan,et al.The causes of early enteral nutrition feeding interruption in critically ill patients: a systematic review[J].PARENTERAL & ENTERAL NUTRITION,2018,(06):285.[doi:10.16151/j.1007-810x.2018.05.008]
[2]林 照,徐 颖,葛卫星,等.苏皖地区部分重症医师对重症病人营养支持指南临床实施情况调查与分析[J].肠外与肠内营养杂志,2018,(06):342.[doi:10.16151/j.1007-810x.2018.11.005]
LIN Zhao,X? Ying,GE Wei-xing,et al.Survey and Analysis of Clinical Practice of Nutritional Support Guidelines for Critically Ill Patients by Some Doctors of Intensive Care Units in Jiangsu and Anhui Area[J].PARENTERAL & ENTERAL NUTRITION,2018,(06):342.[doi:10.16151/j.1007-810x.2018.11.005]
[3]叶向红,宫雪梅,王慧君.减少护理操作中喂养中断 提高早期肠内营养达标率[J].肠外与肠内营养杂志,2019,(01):6.[doi:10.16151/j.1007-810x.2019.01.002]
[4]吴微华,张美齐,彭成忠,等.重症病人鼻肠管超声定位关键部位和切面的
确定及定位效能分析[J].肠外与肠内营养杂志,2020,(01):21.[doi:10.16151/j.1007-810x.2020.01.006]
WU Wei-hua,ZHANG Mei-qi,PENG Cheng-zhong,et al.Determination of key regions and sections and efficiency analysis of
ultrasonic localization of the nasointestinal tube in critically ill patients[J].PARENTERAL & ENTERAL NUTRITION,2020,(06):21.[doi:10.16151/j.1007-810x.2020.01.006]
[5]邰 春,鲁厚清,邵仁德,等.鼻肠管营养在急诊重症病人的临床研究[J].肠外与肠内营养杂志,2020,(01):46.[doi:DOI : 10.16151/j.1007-810x.2020.01.011]
TAI Chun,LU Hou-qing,SHAO Ren-de,et al.The effects of nasojejunal tube feeding in critically ill patients[J].PARENTERAL & ENTERAL NUTRITION,2020,(06):46.[doi:DOI : 10.16151/j.1007-810x.2020.01.011]
[6]姚红林,薛阳阳,江方正,等.腹腔压力分级管理在慢重症病人肠内营养
实施中的效果与评价[J].肠外与肠内营养杂志,2020,(02):100.[doi:10.16151/j.1007-810x.2020.02.008]
YAO Hong-lin,XUE Yang-yang,JIANG Fang-zheng,et al.Effects of intra-abdominal pressure-directed management on enteral
nutrition therapy for patients with chronic critical illness[J].PARENTERAL & ENTERAL NUTRITION,2020,(06):100.[doi:10.16151/j.1007-810x.2020.02.008]
[7]王慧君,叶向红,顾璐璐.重症病人肠内营养误吸监测方法的研究进展[J].肠外与肠内营养杂志,2020,(02):117.[doi:10.16151/j.1007-810x.2020.02.012]
WANG Hui-jun,YE Xiang-hong,GU Lu-lu.Advances in the detection of enteral nutrition aspiration in critical
patients[J].PARENTERAL & ENTERAL NUTRITION,2020,(06):117.[doi:10.16151/j.1007-810x.2020.02.012]
[8]李思宇,高慧,唐志红,等.基于NRS2002的新型冠状病毒肺炎病人营养风险状况及其相关因素分析[J].肠外与肠内营养杂志,2021,(01):41.[doi:DOI : 10.16151/j.1007-810x.2021.01.009]
LI Si-yu,GAO Hui,TANG Zhi-hong,et al.Nutritional risk status and relevant factors of 115 patients with 2019 novel coronavirus pneumonia[J].PARENTERAL & ENTERAL NUTRITION,2021,(06):41.[doi:DOI : 10.16151/j.1007-810x.2021.01.009]
[9]肖 燕,朱子贵,陈嘉成,等.早期高蛋白营养对重症病人住院后期肌力的影响[J].肠外与肠内营养杂志,2021,(02):100.[doi:DOI : 10.16151/j.1007-810x.2021.02.008]
XIAO Yan,ZHU Zi-gui,CHENG Jia-cheng,et al.The effects of early high-dose protein supplementation on later-stage muscle strength in critically ill patients[J].PARENTERAL & ENTERAL NUTRITION,2021,(06):100.[doi:DOI : 10.16151/j.1007-810x.2021.02.008]
[10]陈 玮,王 希,潘思旭,等.糖尿病专用配方和标准肠内营养制剂对重症病人高血糖影响的Meta分析[J].肠外与肠内营养杂志,2021,(06):368.[doi:10.16151/j.1007-810x.2021.06.010]
CHEN Wei,WANG Xi,PAN Si-xu,et al.A Meta-analysis of the effects of diabetes-specific formulas versus standard formulas as enteral nutrition on critically ill patients with hyperglycemia[J].PARENTERAL & ENTERAL NUTRITION,2021,(06):368.[doi:10.16151/j.1007-810x.2021.06.010]